Diabetic Nephropathy
Two combination regimens to reduce albuminuria in diabetic patients compared
Published in Obesity and Diabetes Week, April 4th, 2005
"Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). The early stage of nephropathy is manifested by the presence of low levels of urinary albumin (microalbuminuria or urinary albumin excretion {{>=}}30 and <299 mg/day). Albuminuria is a marker for development of nephropathy in type 2 diabetes and for increased cardiovascular morbidity and mortality. Recent studies have demonstrated the importance of antihypertensive agents that inhibit the renin-angiotensin-aldosterone (RAA) system to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Adiposity increased in first-degree relatives of type 2 diabetic patients - Diabetes Therapy
Early metformin treatment reduces late-developing diabetes complications - Diabetic Nephropathy
Soy diet protects kidneys of obese rats - Diet & Nutrition
Foxtail millet protein increases adiponectin and HDL-cholesterol levels - Obesity and Diabetes
NADPH oxidase plays role in oxidative stress in adipocytes - Acute Coronary Syndrome
AGGRASTAT injection clinical data presented at cardiology meeting - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
